TransMedics Group Inc (NASDAQ:TMDX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 ...

Global Retirement Partners LLC increased its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by ...

TransMedics Group (NASDAQ:TMDX – Get Free Report) will likely be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...

If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...

Beyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMD ...

Analysts predict an EPS of $0.22 and revenue of approximately $109.5 million for the upcoming quarterly report. Legal ...

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...